Literature DB >> 19231096

Diagnostic utility of expression of claudins in non-small cell lung cancer: different expression profiles in squamous cell carcinomas and adenocarcinomas.

Ji Han Jung1, Chan Kwon Jung, Hyun Joo Choi, Kyoung Hwa Jun, Jinyoung Yoo, Seok Jin Kang, Kyo Young Lee.   

Abstract

The claudins, members of a large family of adherent junction proteins, regulate the integrity and function of tight junctions. At present, at least 23 different claudins are known to exist in humans, and claudin gene expression is frequently altered in several human cancers. However, few studies have examined the expression of claudins in lung cancer. This study examined the expression of claudin-1, claudin-3, claudin-4, and claudin-5 proteins using immunohistochemical analysis in 14 normal lung tissue samples and 171 NSCLC samples. All of the claudin proteins examined were expressed in normal bronchial epithelial cells. In the normal peripheral parenchyma, only claudin-5 strongly stained most of the pneumocytes. Claudin-1 expression was stronger in squamous cell carcinomas than in adenocarcinomas, whereas claudin-4 and claudin-5 expression was stronger in adenocarcinomas. Clinically, expression of claudin proteins was not found to be associated with patient survival. These data suggest that the disruption of tight junction protein might be involved in the development of these tumors. Immunohistochemical evaluation of the different expression patterns of claudins in NSCLC suggests that claudin-4, in addition to 1 and 5, might be a useful differential diagnostic marker in Korean people.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19231096     DOI: 10.1016/j.prp.2008.12.015

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  11 in total

1.  Claudin-5 as an immunohistochemical marker for angiosarcoma and hemangioendotheliomas.

Authors:  Markku Miettinen; Maarit Sarlomo-Rikala; Zeng-Feng Wang
Journal:  Am J Surg Pathol       Date:  2011-12       Impact factor: 6.394

2.  Decreased expression of claudin-3 is associated with a poor prognosis and EMT in completely resected squamous cell lung carcinoma.

Authors:  Juanjuan Che; Yifan Yang; Jing Xiao; Pengfei Zhao; Bo Yan; Shuo Dong; Bangwei Cao
Journal:  Tumour Biol       Date:  2015-03-28

Review 3.  Tight junction proteins: from barrier to tumorigenesis.

Authors:  E Aaron Runkle; David Mu
Journal:  Cancer Lett       Date:  2013-06-03       Impact factor: 8.679

4.  Claudin-Targeted Suicide Gene Therapy for Claudin-Overexpressing Tumor Cells by Using Modified Clostridium perfringens Enterotoxin (CPE).

Authors:  Laura-Sophie Beier; Jörg Piontek; Anna Piontek; Jonas Protze; Dennis Kobelt; Wolfgang Walther
Journal:  Methods Mol Biol       Date:  2022

Review 5.  Claudin and ovarian cancer.

Authors:  Chinmoy K Bose; Ashis Mukhopadhyay
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-03-01

6.  miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells.

Authors:  Gang Chen; Ijeoma Adaku Umelo; Shasha Lv; Erik Teugels; Karel Fostier; Peter Kronenberger; Alex Dewaele; Jan Sadones; Caroline Geers; Jacques De Grève
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

Review 7.  The claudin family of proteins in human malignancy: a clinical perspective.

Authors:  Lei Ding; Zhe Lu; Qun Lu; Yan-Hua Chen
Journal:  Cancer Manag Res       Date:  2013-11-08       Impact factor: 3.989

8.  Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype.

Authors:  Shaolei Lu; Kamaljeet Singh; Shamlal Mangray; Rose Tavares; Lelia Noble; Murray B Resnick; Evgeny Yakirevich
Journal:  Mod Pathol       Date:  2012-12-07       Impact factor: 7.842

9.  Prognostic significance of claudin 4 in completely resected adenocarcinoma of the lung.

Authors:  Min Cheol Chae; Chang Kwon Park; Dong Yoon Keum; Ilseon Hwang; Kun Young Kwon; Byeong Churl Jang
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2014-06-05

Review 10.  Claudin-1, A Double-Edged Sword in Cancer.

Authors:  Ajaz A Bhat; Najeeb Syed; Lubna Therachiyil; Sabah Nisar; Sheema Hashem; Muzafar A Macha; Santosh K Yadav; Roopesh Krishnankutty; Shanmugakonar Muralitharan; Hamda Al-Naemi; Puneet Bagga; Ravinder Reddy; Punita Dhawan; Anthony Akobeng; Shahab Uddin; Michael P Frenneaux; Wael El-Rifai; Mohammad Haris
Journal:  Int J Mol Sci       Date:  2020-01-15       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.